Metal-Linked Immunosorbent Assay (Melisa): the Enzyme-Free

Total Page:16

File Type:pdf, Size:1020Kb

Metal-Linked Immunosorbent Assay (Melisa): the Enzyme-Free Theranostics 2016, Vol. 6, Issue 10 1732 Ivyspring International Publisher Theranostics 2016; 6(10): 1732-1739. doi: 10.7150/thno.16129 Research Paper Metal-linked Immunosorbent Assay (MeLISA): the Enzyme-Free Alternative to ELISA for Biomarker Detection in Serum Ru-Jia Yu1†, Wei Ma1†, Xiao-Yuan Liu1, Hong-Ying Jin1, Huan-Xing Han2, Hong-Yang Wang3, He Tian1, Yi-Tao Long1 1. Key Laboratory for Advanced Materials, School of Chemistry & Molecular Engineering, East China University of Science and Technology, P. R. China. 2. Translational Medicine Center, Changzheng Hospital, The Second Military Medical University, P. R. China. 3. Laboratory of Signal Transduction, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, P. R. China. †These authors contributed equally. Corresponding authors: H.T. ([email protected]) or Y.T.L. ([email protected]) © Ivyspring International Publisher. Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. See http://ivyspring.com/terms for terms and conditions. Received: 2016.05.11; Accepted: 2016.05.31; Published: 2016.06.27 Abstract Determination of disease biomarkers in clinical samples is of crucial significance for disease monitoring and public health. The dominating format is enzyme-linked immunosorbent assay (ELISA), which subtly exploits both the antigen-antibody reaction and biocatalytic property of enzymes. Although enzymes play an important role in this platform, they generally suffer from inferior stability and less tolerant of temperature, pH condition compared with general chemical product. Here, we demonstrate a metal-linked immunosorbent assay (MeLISA) based on a robust signal amplification mechanism that faithfully replaces the essential element of the enzyme. As an enzyme-free alternative to ELISA, this methodology works by the detection of α-fetoprotein (AFP), prostatic specific antigen (PSA) and C-reactive protein (CRP) at concentrations of 0.1 ng mL-1, 0.1 ng mL-1 and 1 ng mL-1 respectively. It exhibits approximately two magnitudes higher sensitivity and is 4 times faster for chromogenic reaction than ELISA. The detection of AFP and PSA was further confirmed by over a hundred serum samples from hepatocellular carcinoma (HCC) and prostate cancer patients respectively. Key words: MeLISA Introduction Enzyme-free detection is extremely desirable The development of nanotechnology opens the [1–3] yet still challenging to the engineering of robust way for advances in scientific research [12–18]. With methods which would renovate immunoassay and the synthetic procedure towards nanoparticles having improve current diagnostic techniques. Although been optimized, biosensors based on nanomaterials extensive research has been devoted including the use are moving into clinical practice and commercial of electrochemistry [4–6], fluorescence [7,8] and translation [19]. Conventional gold nanoparticles chemiluminescence [9–11], the requirement of (AuNPs)-based colorimetric detection yields high additional expensive equipment discourages their sensitivity due to the high extinction coefficient and broad application especially in resource limited distance-dependent optical properties [20–25], regions. Since the color generation is the basis of nonetheless, current AuNPs aggregation induced by ELISA, engineering enzyme-free colorimetric assay interparticle crosslinking of biomolecules often could not only well accommodate conventional requires careful and long-time incubation in a buffer immunoassay, but also greatly improve its stability. solution which may cause undesirable aggregation of http://www.thno.org Theranostics 2016, Vol. 6, Issue 10 1733 AuNPs [26]. Robust, ultra-rapid and highly stable Alkynyl silvers induced colorimetric AuNPs aggregation in colorimetric assay still remains assay a challenge. We circumvent this problem by presenting an organic reaction-induced aggregation The formation of alkynyl silvers has wide in aqueous solution which occurs within 1 second. applications in organic synthesis [27,28], This aggregation of AuNPs is triggered by the silver-catalyzed reaction [29,30] and building blocks reaction between terminal alkynes and silver ions, for complex architectures [31,32]. To employ this which has been used as a “traditional test” for organic reaction for colorimetric assay, terminal acetylenic groups (depicted in Fig. 1). We adopt this alkyne-functionalized thiol (5-(1,2-dithiolan-3-yl)-N- classic reaction for the first time in a colorimetric (prop-2-ynyl) pentanamide) was synthesized assay. Surprisingly, it yielded the fastest following previously reported methodology [33]. This AuNPs-based colorimetric process ever reported compound was spontaneously self-assembled onto (Table S1). the surface of AuNPs through Au-S bonds which Herein, this colorimetric assay was integrated could be confirmed by a slight red shift in the UV-Vis into immunoassay by employing the silver ions spectra (Fig. S1). By introducing silver ions to the generation amplification. In our approach, silver alkyne-functionalized AuNPs, the H of the C-H bond nanoparticles (AgNPs) were oxidatively dissolved in of the alkyne was exchanged by the silver (I) species, the presence of hydrogen peroxide to produce immediately forming alkynyl silvers complex. Fig. 2a millions of silver ions. Instead of the standard shows the different tonality of the enzymatic reaction under well-defined conditions in alkyne-functionalized AuNPs solution upon an ELISA test, the robust chemical dissolution and the treatment with different concentrations of silver ultra-rapid colorimetric process ensure a high nitrate; the colour intensity increased at higher reproducible and practical system. The amplification concentrations of silver ions, and the colour remained mechanism exhibits attractive size-modulation, that fixed overnight. The blue coloured solutions were is, AgNPs with differing diameters generate silver characterized by the UV-Vis spectra as demonstrated ions of corresponding amounts, leading to a in Fig. 2b. At higher concentration of silver ions, the controlled detecting range of analyte. That is of vital absorbance at 620 nm (A620 nm) was intensified, which importance for an analytical methodology since the was related to aggregation of AuNPs, whereas the reference ranges for different analytes varies extinction at 520 nm (A520nm), corresponding to significantly. The MeLISA offers a simple but effective dispersed AuNPs, was decreased. The absorbance platform for biomarker detection with high stability ratio between A620 nm and A520 nm was proportional to and robustness. the concentration of silver ions below 10 μM (Fig. 2c), indicating that this colorimetric assay was potentially quantifiable. Figure 1. Schematic representation of the MeLISA for the detection of biomarker. In this sandwich immunoassay, the polystyrene plate is covered with a capture antibody which could anchor the target biomarker. This coating step comprises the blocking procedure with bovine serum albumin to minimize nonspecific interactions. Serum sample with target antigen is added to the plate to allow the reaction between capture antibody and target antigen. Finally, the sandwich immunoassay is formed by the addition of the detection antibody that conjugated with silver nanoparticles. Introduction of hydrogen peroxide initiates the dissolution of AgNPs into silver ions, leading to a rapid aggregation of alkyne-functionalized AuNPs. The aggregation yields a distinct red-to-blue colour change in solution that can be read by eye or a compatible plate reader (for quantification). http://www.thno.org Theranostics 2016, Vol. 6, Issue 10 1734 Figure 2. The aggregation of alkyne-functionalized AuNPs induced by silver ions. a, Visual colour distribution upon treatment of the alkyne-functionalized AuNPs system with various concentrations of Ag+ range from 1 to 400 μM. The photograph was taken less than three seconds after the addition of Ag+. b, UV-Vis spectra of the alkyne-functionalized AuNPs system in the presence of Ag+ with concentrations from 1 to 400 μM. The absorbance at 620 nm indicates the aggregation of alkyne-functionalized AuNPs. c, Plot of A620 nm/A520 nm against different concentrations of Ag+. The inset is a linear relationship at low concentration of Ag+. Error bars are based on three independent measurements. d, e, Transmission electron microscopy (TEM) images of the dispersed and aggregated alkyne-functionalize AuNPs in the absence (d) and presence (e) of Ag+. Scale bar: 200 nm. f, DLS analysis of alkyne-functionalized AuNPs in the presence of 0 μM (gray), 4 μM (blue), 8 μM (orange), 40 μM (purple) silver ions. The aggregation was due to the formation of compound. Taken together, the aggregation of alkynyl silvers which could change the surface charge alkyne-functionalized AuNPs induced by silver ions of alkyne-functionalized AuNPs. The high efficient can be used in colorimetric assay due to the rapid nature of this organic reaction, results in a fast response, high stability and capability to produce an aggregation within 1 second at room temperature. intense optical response. This is the most rapid AuNPs-based colorimetric process ever reported. The aggregation of MeLISA for biomarker detection alkyne-functionalized AuNPs could be directly We used the dissolution of AgNPs for signal confirmed by transmission electron microscopy amplification, taking the place of enzymatic process. (TEM) images. It clearly displayed a dispersed
Recommended publications
  • The Journal of the International Federation of Clinical Chemistry and Laboratory Medicine in This Issue
    June 2021 ISSN 1650-3414 Volume 32 Number 2 Communications and Publications Division (CPD) of the IFCC Editor-in-chief: Prof. János Kappelmayer, MD, PhD Faculty of Medicine, University of Debrecen, Hungary e-mail: [email protected] The Journal of the International Federation of Clinical Chemistry and Laboratory Medicine In this issue Introducing the eJIFCC special issue on “POCT – making the point” Guest editor: Sergio Bernardini 116 Controlling reliability, interoperability and security of mobile health solutions Damien Gruson 118 Best laboratory practices regarding POCT in different settings (hospital and outside the hospital) Adil I. Khan 124 POCT accreditation ISO 15189 and ISO 22870: making the point Paloma Oliver, Pilar Fernandez-Calle, Antonio Buno 131 Utilizing point-of-care testing to optimize patient care James H. Nichols 140 POCT: an inherently ideal tool in pediatric laboratory medicine Siobhan Wilson, Mary Kathryn Bohn, Khosrow Adeli 145 Point of care testing of serum electrolytes and lactate in sick children Aashima Dabas, Shipra Agrawal, Vernika Tyagi, Shikha Sharma, Vandana Rastogi, Urmila Jhamb, Pradeep Kumar Dabla 158 Training and competency strategies for point-of-care testing Sedef Yenice 167 Leading POCT networks: operating POCT programs across multiple sites involving vast geographical areas and rural communities Edward W. Randell, Vinita Thakur 179 Connectivity strategies in managing a POCT service Rajiv Erasmus, Sumedha Sahni, Rania El-Sharkawy 190 POCT in developing countries Prasenjit Mitra, Praveen Sharma 195 In this issue How could POCT be a useful tool for migrant and refugee health? Sergio Bernardini, Massimo Pieri, Marco Ciotti 200 Direct to consumer laboratory testing (DTCT) – opportunities and concerns Matthias Orth 209 Clinical assessment of the DiaSorin LIAISON SARS-CoV-2 Ag chemiluminescence immunoassay Gian Luca Salvagno, Gianluca Gianfilippi, Giacomo Fiorio, Laura Pighi, Simone De Nitto, Brandon M.
    [Show full text]
  • 1995) Borrelia Burgdorferi-Specific T Lymphocytes Induce Severe Destructive Lyme Arthritis
    LTT (Lymphozyten-Proliferationstest, „Lymphozyten-Transformationstest“) Interferon Gamma Test, ELISpot (T-Cell Spot), dem Lymphozytentransformationstest bei Borreliose und bei anderen Infektionskrankheiten Im Lymphozyten-Proliferationstest, auch Lymphozyten-Transformationstest genannt (LTT), wird die Proliferationskapazität von Lymphozyten dargestellt. Der Test dient der Bewertung des Immunstatus oder der Diagnose einer speziellen Sensibilisierung. In the Lymphocyte proliferation assay, also known as lymphocyte transformation test (LTT), the proliferation capacity of lymphocytes is shown. The test is used to evaluate the immune status or the diagnosis of specific sensitization of an object. Im Interferon Gamma Test, dem ELISPOT (Enzyme-Linked ImmunoSpot), auch T- Cellspot genannt, wird durch die Bestimmung der Zytokin – Produktion die Quantität und die Qualität einer T – Zell - Immunantwort zeitnah dokumentiert. In the Interferone Gamma Test, ELISPOT (Enzyme-Linked ImmunoSpot), also called T-Cell spot, represented by the determination of cytokine – Production, the quantity and quality of T - cell - immune response in a timely manner is documented. Lim LC, England DM, DuChateau BK, Glowacki NJ, Schell RF (1995) Borrelia burgdorferi-specific T lymphocytes induce severe destructive Lyme arthritis. Infect. Immun. 63, 1400-1408. Dwyer JM et al. (1979) Behavior of human immunoregulatory cells in culture. L Variables requiring consideration for clinical studies. Clin Exp Immunol 38, 499-513 Johnson C, Dwyer JM (1981) Quantitation of spontaneous suppressor cell activity in human cord blood lymphocytes and their behavior in culture (abstract). Fed Proc 40, 1075 Czerkinsky C, Nilsson L, Nygren H, Ouchterlony O, Tarkowski A (1983) A solid-phase enzyme- linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells.J Immunol Methods 65 (1–2), 109–121.
    [Show full text]
  • Ampath Medical Surveillance Guidelines Metal Chemicals
    AMPATH MEDICAL SURVEILLANCE GUIDELINES METAL CHEMICALS TABLE OF CONTENTS Introduction 3 Definitions 4 Biological monitoring 7 Biological effect monitoring 15 Health program 15 Food handler’s health program 16 Driver’s health program 16 Substance abuse in the workplace 17 Alcohol in the workplace 17 Target organs for alcohol abuse 21 Drugs in the workplace 22 Ampath drugs of abuse screening and confirmatory tests on urine 23 Conditions under which a pathologist will testify in court 23 Chain of custody 24 Hazardous chemical regulations 25 Designing and implementing a program of medical surveillance 25 Assessment of potential exposure 25 Table 3 substances 26 Available tests 27 Test interpretation 31 Ampath Quality Assurance 33 Designing exposure profiles 34 Work related hazardous chemical exposure 36 Chemical exposure: DNA adducts 37 Target organs for chemical exposure 39 Chemical exposure profiles 40 Aniline 40 Acetone 41 Benzene 42 Carbon disulphide 43 Carbon monoxide 44 Cyanide 45 Ethyl benzene 46 NN-dimethylformamide 47 Furfural 48 N-hexane 49 © Ampath Medical Surveillance Guideline 1 Isocyanate 50 Methanol 51 Methyl chloroform 52 Methyl ethyl ketone 53 Methyl isobutyl ketone 54 Nitrobenzene 55 Organophosphorous cholinesterase inhibitors 56 Paraquat 57 Parathion 58 Pentachlorophenol 59 Perchloroethylene 60 Phenol 61 Polycyclic aromatic hydrocarbon(PAH) 62 Styrene 64 Toluene 65 Trichloroethylene 67 Xylene 68 Metals 69 Diagnosis and investigation of occupational exposure to metals; a general review 69 Target organs for metal exposure
    [Show full text]
  • Ampath Desk Reference: Guide to Laboratory Tests
    Ampath Guide to Lab Tests front cover final repro outlines 15 March 2016.
    [Show full text]
  • Abstracts of Poster Presentations
    Abstracts of Poster Presentations To view the full program, please visit the Congress website www.kenes.com/aps Downloaded from lup.sagepub.com at University Library Utrecht on March 17, 2015 loth ktertSic (Qn nsanAtiopuipdAMibocEes PFates 584 ANTIPHOSPHOLIPID ANTIBODIES IN PATIENTS WITH DEVELOPMENT OF ANTIPHOSDPHOLIPID-ANTIBODIES AND INTOLERANCE TO METALS IN THE ORAL CAVITY FACrOR V-INHIBITOR AFTER CIPROFLOXACIN IN TWO CASES H. Kucerova', J. Prochazkovat, I. Janatkova2, J. Bartova', T. Fucikova2 W.Miesbachl, J. Vogte, D. Peez3, B. Buehler', G. Asmelashl', 'Institute ofDental Research, 1st Medical Faculty, 2Institute ofClinical 1. Scharrerl Imnmunology andAllergology, General Faculty Hospital, Prague, 'J W.Goethe-University, Frankfurt, 25t. Vincenz Hospital, Mainz, Czech Republic 3Justus Liebig University, Frankfurt, Germany Dental alloys are not a physiological part of the organism. Metals can cause The development of factor V-inhibitor is very rare, especially in the production of autoantibodies in sensitive individuals as well as other combination with the antiphospholipid (aPL)-antibodies. The present paper undesired side effects. The aim of this presentation is to evaluate the describes two patients with factor V-inhibitor and aPL-antibodies after presence of antiphospholipid antibodies in sera of patients with oral trcatment with ciprofloxacin. Lupus anticoagulants (LA) were assayed discomfort and the occurrence of pathological galvanic currents in the oral according to the criteria of SSC of the ISTH, ACL by an ELISA, factor V- cavity. The patients were diagnosed by measurement of galvanic features inhibitor by the Bethesda method. with the device Odontologic accompanied by the modified method ofblastic Q.Oe.atirti 74 years old was treated with ciprofloxacin for a postoperative transfonnation for metals (Melisa) and by the anamnestic data.
    [Show full text]
  • XXI Fungal Genetics Conference Abstracts
    Fungal Genetics Reports Volume 48 Article 17 XXI Fungal Genetics Conference Abstracts Fungal Genetics Conference Follow this and additional works at: https://newprairiepress.org/fgr This work is licensed under a Creative Commons Attribution-Share Alike 4.0 License. Recommended Citation Fungal Genetics Conference. (2001) "XXI Fungal Genetics Conference Abstracts," Fungal Genetics Reports: Vol. 48, Article 17. https://doi.org/10.4148/1941-4765.1182 This Supplementary Material is brought to you for free and open access by New Prairie Press. It has been accepted for inclusion in Fungal Genetics Reports by an authorized administrator of New Prairie Press. For more information, please contact [email protected]. XXI Fungal Genetics Conference Abstracts Abstract XXI Fungal Genetics Conference Abstracts This supplementary material is available in Fungal Genetics Reports: https://newprairiepress.org/fgr/vol48/iss1/17 : XXI Fungal Genetics Conference Abstracts XXI Fungal Genetics Conference Abstracts Plenary sessions Cell Biology (1-87) Population and Evolutionary Biology (88-124) Genomics and Proteomics (125-179) Industrial Biology and Biotechnology (180-214) Host-Parasite Interactions (215-295) Gene Regulation (296-385) Developmental Biology (386-457) Biochemistry and Secondary Metabolism(458-492) Unclassified(493-502) Index to Abstracts Abstracts may be cited as "Fungal Genetics Newsletter 48S:abstract number" Plenary Abstracts COMPARATIVE AND FUNCTIONAL GENOMICS FUNGAL-HOST INTERACTIONS CELL BIOLOGY GENOME STRUCTURE AND MAINTENANCE COMPARATIVE AND FUNCTIONAL GENOMICS Genome reconstruction and gene expression for the rice blast fungus, Magnaporthe grisea. Ralph A. Dean. Fungal Genomics Laboratory, NC State University, Raleigh NC 27695 Rice blast disease, caused by Magnaporthe grisea, is one of the most devastating threats to food security worldwide.
    [Show full text]
  • MSACL 2014 EU September 1 Austria 2-5, 2014 Salzburg, Con Dence in Results MSACL 2014 EU
    The Association for MS Mass Spectrometry: ACL Applications to the Clinical Lab MSACL 2014 EU September 2-5, 2014 Salzburg, Austria 1 2014 EU September MSACL Condence in Results MSACL 2014 EU ™ high-performance medical devices for in vitro diagnostic use ™ Prelude MD ™ ™ Endura MD ™ mass spectrometer, and Thermo Salzburg, Austria ™ ClinQuan MD ™ LC-MS for in vitro diagnostic use September 2-5 The 1st Annual European Congress Visit us in booth #12 • st Annual European Congress Program Congress Annual European e licensed for limited use only to Thermo r d parties including Shutterstock, and a r by thi Supported in part by generous contributions from: For in vitro diagnostic use. Not available in all countries. San Jose, CA USA i s Endura MD Mass ISO 13485 Prelude MD HPLC Spectrometer ClinQuan MD Software AD64157-EN 0614S-Rev.B MSACLMASS SPECTROMETRY SOLUTIONS FOR IN2014 VITRO DIAGNOSTICS EU The variety of your clinical research Salzburg, Austria demands a variety of technologies September 2-5 The 1st Annual European Congress You’re not the only one who needs to trust the test results ACCURACY THE FIRST TIME No one analytical technology can adequately reveal everything you need ! GC-Triple Quadrupole to know about your sample. Bruker offers the broadest range of high ! LC-Triple Quadrupole Clinicians and patients count on the most reliable diagnostic answers. We want you to be confident that results are as timely performance, easy-to-use, and expertly supported analytical systems ! LC-QqTOF and accurate as possible. SCIEX Diagnostics offers an in vitro diagnostics solution with exceptional assay performance that helps to overcome any clinical research challenge.
    [Show full text]
  • August 2021 Vectorborne Infectious Diseases
    1913.),Culebra Jonas( OilLie Cut, on(1880−1940) canvas, Panama 60 Canal in The x 50 Conquerors in/ 152.4 cm x 127 cm. InfectiousDiseases Vectorborne Image copyright © The Metropolitan Museum of Art, New York, NY, United States. Image source: Art Resource, New York, NY, United States. August 2021 ® Peer-Reviewed Journal Tracking and Analyzing Disease Trends Pages 2008–2250 ® EDITOR-IN-CHIEF D. Peter Drotman ASSOCIATE EDITORS EDITORIAL BOARD Charles Ben Beard, Fort Collins, Colorado, USA Barry J. Beaty, Fort Collins, Colorado, USA Ermias Belay, Atlanta, Georgia, USA Martin J. Blaser, New York, New York, USA David M. Bell, Atlanta, Georgia, USA Andrea Boggild, Toronto, Ontario, Canada Sharon Bloom, Atlanta, Georgia, USA Christopher Braden, Atlanta, Georgia, USA Richard Bradbury, Melbourne, Australia Arturo Casadevall, New York, New York, USA Corrie Brown, Athens, Georgia, USA Benjamin J. Cowling, Hong Kong, China Kenneth G. Castro, Atlanta, Georgia, USA Michel Drancourt, Marseille, France Christian Drosten, Charité Berlin, Germany Paul V. Effler, Perth, Australia Isaac Chun-Hai Fung, Statesboro, Georgia, USA Anthony Fiore, Atlanta, Georgia, USA Kathleen Gensheimer, College Park, Maryland, USA David O. Freedman, Birmingham, Alabama, USA Rachel Gorwitz, Atlanta, Georgia, USA Peter Gerner-Smidt, Atlanta, Georgia, USA Duane J. Gubler, Singapore Stephen Hadler, Atlanta, Georgia, USA Scott Halstead, Arlington, Virginia, USA Matthew J. Kuehnert, Edison, New Jersey, USA Nina Marano, Atlanta, Georgia, USA David L. Heymann, London, UK Martin I. Meltzer, Atlanta, Georgia, USA Keith Klugman, Seattle, Washington, USA David Morens, Bethesda, Maryland, USA S.K. Lam, Kuala Lumpur, Malaysia J. Glenn Morris, Jr., Gainesville, Florida, USA Shawn Lockhart, Atlanta, Georgia, USA Patrice Nordmann, Fribourg, Switzerland John S.
    [Show full text]
  • Immunomodulation of T Helper Cells by Tumor Microenvironment in Oral
    ORIGINAL RESEARCH published: 07 May 2021 doi: 10.3389/fimmu.2021.643298 Immunomodulation of T Helper Cells by Tumor Microenvironment in Oral Cancer Is Associated With CCR8 Expression and Rapid Membrane Edited by: Vitamin D Signaling Pathway Lewis Z. Shi, University of Alabama at Birmingham, 1 ´ 2 3,4,5 1 United States Marco Fraga , Milly Yañez , Macarena Sherman , Faryd Llerena , Mauricio Hernandez 6, Guillermo Nourdin 6, Francisco A´ lvarez 6, Joaqu´ın Urrizola 7, Reviewed by: Ce´ sar Rivera 8, Liliana Lamperti 1,9, Lorena Nova 10, Silvia Castro 1, Omar Zambrano 11, Hongru Zhang, 11 ´ 12 12 12 12 University of Pennsylvania, Alejandro Cifuentes , Leon Campos , Sergio Moya , Juan Pastor , Marcelo Nuñez , 12 12 ´ 1 ´ 13 14 United States Jorge Gatica , Jorge Figueroa , Felipe Zuñiga , Carlos Salomon , Gustavo Cerda , 5 1 15 16 Greg M. Delgoffe, Ricardo Puentes , Gonzalo Labarca , Mabel Vidal , Reuben McGregor 1 University of Pittsburgh, and Estefania Nova-Lamperti * United States 1 Molecular and Translational Immunology Laboratory, Clinical Biochemistry and Immunology Department, Pharmacy Faculty, *Correspondence: Universidad de Concepcio´ n, Concepcio´ n, Chile, 2 Anatomy Pathology Unit and Dental Service, Oral Pathology Department, Estefania Nova-Lamperti Hospital Las Higueras, Talcahuano, Chile, 3 Anatomy Pathology Unit, Hospital Guillermo Grant Benavente and Universidad [email protected]; de Concepcio´ n, Concepcio´ n, Chile, 4 Head and Neck Service, Hospital Guillermo Grant Benavente, Concepcio´ n, Chile, [email protected] 5 Dental
    [Show full text]
  • IUPAC Glossary of Terms Used in Immunotoxicology (IUPAC Recommendations 2012)*
    Pure Appl. Chem., Vol. 84, No. 5, pp. 1113–1295, 2012. http://dx.doi.org/10.1351/PAC-REC-11-06-03 © 2012 IUPAC, Publication date (Web): 16 February 2012 IUPAC glossary of terms used in immunotoxicology (IUPAC Recommendations 2012)* Douglas M. Templeton1,‡, Michael Schwenk2, Reinhild Klein3, and John H. Duffus4 1Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada; 2In den Kreuzäckern 16, Tübingen, Germany; 3Immunopathological Laboratory, Department of Internal Medicine II, Otfried-Müller-Strasse, Tübingen, Germany; 4The Edinburgh Centre for Toxicology, Edinburgh, Scotland, UK Abstract: The primary objective of this “Glossary of Terms Used in Immunotoxicology” is to give clear definitions for those who contribute to studies relevant to immunotoxicology but are not themselves immunologists. This applies especially to chemists who need to under- stand the literature of immunology without recourse to a multiplicity of other glossaries or dictionaries. The glossary includes terms related to basic and clinical immunology insofar as they are necessary for a self-contained document, and particularly terms related to diagnos- ing, measuring, and understanding effects of substances on the immune system. The glossary consists of about 1200 terms as primary alphabetical entries, and Annexes of common abbre- viations, examples of chemicals with known effects on the immune system, autoantibodies in autoimmune disease, and therapeutic agents used in autoimmune disease and cancer. The authors hope that among the groups who will find this glossary helpful, in addition to chemists, are toxicologists, pharmacologists, medical practitioners, risk assessors, and regu- latory authorities. In particular, it should facilitate the worldwide use of chemistry in relation to occupational and environmental risk assessment.
    [Show full text]
  • MELISA-TEK ® RUMINANT KIT - Cat
    MMEELLIISSAA--TTEEKK®® SPECIATION KITS FOR MEAT & BONE MEALS AND ANIMAL FEEDS For the Detection of Animal Species Content Of Meat & Bone Meals and Animal Feeds by Monoclonal Enzyme Linked ImmunoSorbent Assay INSTRUCTIONS FOR USE MELISA-TEK ® RUMINANT KIT - Cat. No. SE110017 MELISA-TEK ® PORK KIT - Cat. No. SE110018 3050 Spruce Street, St. Louis, MO 63103 USA Tel: (800)521-8956 Fax: (800)325-5052 Sigma-Aldrich.com Manufactured By: ELISA Technologies, Inc. 2501 NW 66 th Court Gainesville, FL 32653 USA Tel: (352) 337-3929 Fax: (352) 337-3928 www.elisa-tek.com CONTENTS Page Number 2 TABLE OF CONTENTS 3 GENERAL DESCRIPTION 3 TEST PRINCIPLE 3 IMPORTANCE OF TROPONIN -I DETECTION 3 SAFETY INSTRUCTIONS 3 STORAGE AND STABILITY 4 MATERIA LS PROVIDED 4 MATERIALS NOT PROVIDED 5 PREPARING A PLATE PLAN 6 KIT COMPONENT PREPARATION 6 PREPARE SAMPLES TO BE TESTED 6 PREPARE THE TEST CONTROLS 7 ASSAY PROCEDURE 8 RESULTS WORKSHEET 8 PERFORMANCE CHARACTERISTICS 9 KIT SPECIFICITY 9 KIT LIMITATIONS 9 DISCLAIMER 10 SPECIES KITS LISTING 2 MELISA-TEK ® SPECIES ASSAY KIT INSTRUCTIONS General Description : The ELISA Technologies MELISA-TEK ® Species assay kit is an immunoassay for the detection of species specific troponin-I. Troponin-I is a heat stable, muscle specific protein and, as such, this kit is intended to detect muscle tissue in extracts made from cooked meat and feed products such as meat meals and meat and bone meals. Test Principle: This test is a sandwich ELISA that allows for detection of muscle tissue in extracts made from cooked meat or feed products (e.g., meat meals and meat and bone meals).
    [Show full text]
  • A Novel Lymphocyte Transformation Test (LTT-MELISAR) for Lyme Borreliosis
    Diagnostic Microbiology and Infectious Disease 57 (2007) 27–34 www.elsevier.com/locate/diagmicrobio A novel lymphocyte transformation test (LTT-MELISAR) for Lyme borreliosis Elizabeth Valentine-Thona,4, Karsten Ilsemannb, Martin Sandkampc aDepartment of Immunology, Laboratory Center Bremen, 28205 Bremen, Germany bDepartment of Serology in Laboratory Center Bremen, 28205 Bremen, Germany cLaboratory Center Bremen, 28205 Bremen, Germany Received 18 April 2006; accepted 7 June 2006 Abstract Diagnosis of active Lyme borreliosis (LB) remains a challenge in clinically ambiguous, serologically indeterminant, and polymerase chain reaction-negative patients. Lymphocyte transformation tests (LTTs) have been applied to detect specific cellular immune reactivity, but their clinical application has been severely hampered by the poorly defined Borrelia antigens and nonstandardized LTT formats used. In this study, we describe the development and clinical relevance of a novel LTT using a validated format (MELISAR) together with well-defined recombinant Borrelia-specific antigens. From an initial screening of 244 patients with suspected Borrelia infection or disease, 4 informative recombinant antigens were selected: OspC (Borrelia afzelii), p41-1 (Borrelia garinii), p41-2 (B. afzelii), and p100 (B. afzelii). Thereafter, 30 seronegative healthy controls were tested in LTT-MELISAR to determine specificity, 68 patients were tested in parallel to determine reproducibility, and 54 lymphocyte-reactive symptomatic patients were tested before and after antibiotic therapy to assess clinical relevance. Most (86.2%) of the 36.9% (90/244) LTT-MELISAR-positive patients were seropositive and showed symptoms of active LB. Specificity was 96.7% and reproducibility 92.6%. After therapy, most patients (90.7%) showed negative or markedly reduced lymphocyte reactivity correlating with clinical improvement.
    [Show full text]